Tag: therapeutics
-
ONK Therapeutics Snags $21.5M for NK Cell Therapies
San Diego- and Galway, Ireland-based ONK Therapeutics announced today that it has raised $21.5M in its Series A funding. The funding was led by Acorn Bioventures and ALSHC, plus Cormorant Asset Management. The startup says it is developing optimally en…
-
Regulus Therapeutics Names VP
San Diego-based Regulus Therapeutics, a biopharmaceuticals firm focused on targeted microRNA, said it has named Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceutical Development. Ahmadian previously was Vice President & Resident Dir…
-
858 Therapeutics Exits Stealth Mode With $60M Funding
San Diego-based 858 Therapeutics, a biotech startup focused on small molecules, has exited stealth mode and announced a $60M, Series A funding. According to the company, the funding was led by founding investor Versant Ventures, with participation from…
-
i2020 Accelerator Launches Two Oncology Startups
San Diego-based i2020 Acclerator, a startup accelerator company which is backed by Torrey Pines Investment, announced this morning that it has launched two new startups. The company said that it has launched Gwynant Therapeutics and Celyn Therapeutics,…
-
ADARx Takes $75M For RNA Therapeutics
San Diego-based ADARx Pharmaceuticals, a biotechnology company which is developing RNA targeting therapeutics, said Wednesday that it has raised $75M in a Series B funding. The funding was co-led by SR One Capital Management and OrbiMed Advisors, and a…
-
Boundless Bio Names General Counsel
San Diego-based oncology drug developer Boundless Bio said this morning that it has aappointed Jessica Oien as its new General Counsel and Corporate Secretary. Oien was previously General Counsel and Corporate Secretary at the public biotechnology comp…
-
Engrail Therapeutics Adds $32M In Series A Funding
San Diego-based pharmaceuticals startup Engrail Therapeutics, which is focused on neuroscience pharmaceuticals, said today that it has raised an additional $32M in its Series A funding round, bringing its total raised in the Series A to $64M. The new f…
-
Aristea Snags $63M In Series B
San Diego-based immunology startup Aristea Therapeutics says it has raised $63M in a Series B financing round, which was led by Fidelity Management & Research Company, LLC, along with Novo Holdings A/S, plus Arena Pharmaceuticals and funds managed by T…
-
Entos Finds $53M For Drug Design Platform
San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. The funding was led by Coatue, and also included Catalio Capi…